COVID-19: Drug Targets and Potential Treatments - PubMed

Affiliations

• PMID: 32511912
• DOI: 10.1021/acs.jmedchem.0c00606

Free article

Review

COVID-19: Drug Targets and Potential Treatments

Carmen Gil et al. J Med Chem. 2020.

Free article

Abstract

Currently, humans are immersed in a pandemic caused by the emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which threatens public health worldwide. To date, no drug or vaccine has been approved to treat the severe disease caused by this coronavirus, COVID-19. In this paper, we will focus on the main virus-based and host-based targets that can guide efforts in medicinal chemistry to discover new drugs for this devastating disease. In principle, all CoV enzymes and proteins involved in viral replication and the control of host cellular machineries are potentially druggable targets in the search for therapeutic options for SARS-CoV-2. This Perspective provides an overview of the main targets from a structural point of view, together with reported therapeutic compounds with activity against SARS-CoV-2 and/or other CoVs. Also, the role of innate immune response to coronavirus infection and the related therapeutic options will be presented.

Similar articles

• Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.

  Artese A, Svicher V, Costa G, Salpini R, Di Maio VC, Alkhatib M, Ambrosio FA, Santoro MM, Assaraf YG, Alcaro S, Ceccherini-Silberstein F. Artese A, et al. Drug Resist Updat. 2020 Dec;53:100721. doi: 10.1016/j.drup.2020.100721. Epub 2020 Aug 26. Drug Resist Updat. 2020. PMID: 33132205 Free PMC article. Review.

• The race to treat COVID-19: Potential therapeutic agents for the prevention and treatment of SARS-CoV-2.

  Shagufta, Ahmad I. Shagufta, et al. Eur J Med Chem. 2021 Mar 5;213:113157. doi: 10.1016/j.ejmech.2021.113157. Epub 2021 Jan 12. Eur J Med Chem. 2021. PMID: 33486200 Free PMC article. Review.

• TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351).

  Lee J, Lee J, Kim HJ, Ko M, Jee Y, Kim S. Lee J, et al. Microbiol Spectr. 2021 Sep 3;9(1):e0047221. doi: 10.1128/Spectrum.00472-21. Epub 2021 Aug 11. Microbiol Spectr. 2021. PMID: 34378968 Free PMC article.

• Elucidating the Drug Repurposing Spectra of COVID-19 with its Analogues SARS and MERS.

  Mishra J, Prasun C, Sahoo PK, Nair MS. Mishra J, et al. Mini Rev Med Chem. 2021;21(20):3191-3202. doi: 10.2174/1389557521666210225114733. Mini Rev Med Chem. 2021. PMID: 33632095 Review.

• Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.

  Abdurrahman L, Fang X, Zhang Y. Abdurrahman L, et al. Curr Mol Med. 2022;22(7):621-639. doi: 10.2174/1566524021666211013121831. Curr Mol Med. 2022. PMID: 34645374 Review.

Cited by

• Various theranostics and immunization strategies based on nanotechnology against Covid-19 pandemic: An interdisciplinary view.

  Chatterjee S, Mishra S, Chowdhury KD, Ghosh CK, Saha KD. Chatterjee S, et al. Life Sci. 2021 Aug 1;278:119580. doi: 10.1016/j.lfs.2021.119580. Epub 2021 May 12. Life Sci. 2021. PMID: 33991549 Free PMC article. Review.

• Molecular Docking and In-Silico Analysis of Natural Biomolecules against Dengue, Ebola, Zika, SARS-CoV-2 Variants of Concern and Monkeypox Virus.

  Dassanayake MK, Khoo TJ, Chong CH, Di Martino P. Dassanayake MK, et al. Int J Mol Sci. 2022 Sep 22;23(19):11131. doi: 10.3390/ijms231911131. Int J Mol Sci. 2022. PMID: 36232431 Free PMC article.

• α_V β₆ Integrin: An Intriguing Target for COVID-19 and Related Diseases.

  Bugatti K. Bugatti K. Chembiochem. 2021 Aug 3;22(15):2516-2520. doi: 10.1002/cbic.202100209. Epub 2021 Jun 15. Chembiochem. 2021. PMID: 34132013 Free PMC article.

• Selective, broad-spectrum antiviral photodynamic disinfection with dicationic imidazolyl chlorin photosensitizers.

  Arnaut ZA, Pinto SMA, Aroso RT, Amorim AS, Lobo CS, Schaberle FA, Pereira D, Núñez J, Nunes SCC, Pais AACC, Rodrigues-Santos P, de Almeida LP, Pereira MM, Arnaut LG. Arnaut ZA, et al. Photochem Photobiol Sci. 2023 Nov;22(11):2607-2620. doi: 10.1007/s43630-023-00476-4. Epub 2023 Sep 11. Photochem Photobiol Sci. 2023. PMID: 37755667

• A Workflow of Integrated Resources to Catalyze Network Pharmacology Driven COVID-19 Research.

  Zahoránszky-Kőhalmi G, Siramshetty VB, Kumar P, Gurumurthy M, Grillo B, Mathew B, Metaxatos D, Backus M, Mierzwa T, Simon R, Grishagin I, Brovold L, Mathé EA, Hall MD, Michael SG, Godfrey AG, Mestres J, Jensen LJ, Oprea TI. Zahoránszky-Kőhalmi G, et al. J Chem Inf Model. 2022 Feb 14;62(3):718-729. doi: 10.1021/acs.jcim.1c00431. Epub 2022 Jan 20. J Chem Inf Model. 2022. PMID: 35057621 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • American Chemical Society
  • Digital CSIC Spanish National Research Council

• Other Literature Sources

  • The Lens - Patent Citations Database

• Miscellaneous

  • NCI CPTAC Assay Portal